Personalizing Drug Therapy: The Role of Pharmacokinetics and Therapeutic Drug Monitoring

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".

Deadline for manuscript submissions: 30 April 2026 | Viewed by 25

Special Issue Editors


E-Mail Website
Guest Editor
1. University Hospital of Salerno, 84100 Salerno, Italy
2. Department of Medicine, Surgery and Dentistry, University of Salerno, Fisciano, Italy
Interests: pharmacology; medicinal chemistry; drug monitoring; chromatography; mass spectrometry

E-Mail Website
Guest Editor
1. University Hospital of Salerno, 84100 Salerno, Italy
2. Department of Medicine, Surgery and Dentistry, University of Salerno, Fisciano, Italy
Interests: laboratory medicine; biochemistry; drug monitoring; chromatography; mass spectrometry
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Recent developments in clinical pharmacology and bioanalytical technology are revolutionizing customized medication treatment. Standardized dosing can often be subtherapeutic or potentially dangerous; this is due to interindividual variability in drug metabolism, distribution, and excretion, which is influenced by genetic, physiological, and pathological variables. Personalized dosing approaches can be developed through therapeutic drug monitoring (TDM) and pharmacokinetic modeling, even for medications with a narrow therapeutic index, such as immunosuppressants, antimicrobials, and antiepileptics. This Special Issue aims to explore the critical roles that TDM and pharmacokinetics play in improving treatment efficacy and reducing toxicity in different patient groups, including pediatric and geriatric patients. We seek studies on novel TDM approaches; the combination of Bayesian predictions and population pharmacokinetics; practical clinical applications; cutting-edge technologies such as microsampling and high-resolution LC-MS/MS platforms; the clinical application of TDM methods; and the practical implications of PK models in real-world clinical settings. This Special Issue particularly focuses on the interplay between pharmacokinetics (PK) and TDM, which are necessary for tailoring drug regimens according to unique patient characteristics. Moreover, it seeks to promote an evidence-based, patient-centered approach for medication personalization.

Dr. Bruno Charlier
Dr. Viviana Izzo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • therapeutic drug monitoring (TDM)
  • pharmacokinetics
  • personalized medicine
  • LC-MS/MS bioanalysis
  • dose individualization
  • precision pharmacotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop